CD36 and osteosarcoma: ZCCHC12 can promote the progression of osteosarcoma through the PI3K/AKT pathway, and ZCCHC12+ tumor cells in papillary thyroid cancer interact with CD36+ pro-inflammatory macrophages to promote tumor progression and recurrence (58).